Role of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in Bone Loss Related to Advanced Chronic Obstructive Pulmonary Disease

Samankaltaisia teoksia

• Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss
  Tekijä: Trouvin, Anne-Priscille, et al.
  Julkaistu: (2010)
• Does Osteoprotegerin or Receptor Activator of Nuclear Factor-κB Ligand Mediate the Association between Bone and Coronary Artery Calcification?
  Tekijä: Bakhireva, Ludmila N., et al.
  Julkaistu: (2008)
• Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease
  Tekijä: Kearns, Ann E., et al.
  Julkaistu: (2008)
• Imbalance of osteoprotegerin/receptor activator of nuclear factor-κB ligand and oxidative stress in patients with obstructive sleep apnea-hypopnea syndrome
  Tekijä: Ma, Xiao-Rong, et al.
  Julkaistu: (2019)
• Immunolocalization of receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin (OPG) in Meckel's cartilage compared with developing endochondral bones in mice
  Tekijä: Sakakura, Yasunori, et al.
  Julkaistu: (2005)